COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.

Karissa N ArcaJonathan H SmithChia-Chun Chiang Amaal J StarlingCarrie E RobertsonRashmi B Halker SinghTodd J Schwedt Narayan R Kissoon Ivan Garza Todd D Rozen Christopher J Boes Mark A WhealyJuliana H VanderPluym

Published in: Headache (2020)

Scientific information regarding the COVID-19 pandemic is constantly evolving, and limited or contradictory information can lead to confusion for both patients and clinicians. It is recommended that prior to prescribing non-steroidal anti-inflammatory drugs and steroids for the treatment of headache, clinicians have open discussions with their patients about the potential risks and benefits of using these medications during the COVID-19 pandemic. This manuscript summarizes the currently available evidence and understanding about these risks and benefits to help clinicians navigate such discussions.

Keyphrases

anti inflammatory drugs
end stage renal disease
ejection fraction
newly diagnosed
palliative care
chronic kidney disease
prognostic factors
primary care
peritoneal dialysis
coronavirus disease
sars cov
healthcare
human health
minimally invasive
risk assessment
social media
climate change
advance care planning